An analysis of the landmark EMPA-Kidney trial underlines the need for urgency when prescribing SGLT2 inhibitors in patients at risk of chronic kidney disease progression, with...
Given recent increases in the prevalence of obesity, both metabolic dysfunction-associated steatotic liver disease (MASLD) and bariatric surgery are becoming increasingly common, with bariatric surgery offering...
Mustafa Arici, MD Credit: LinkedIn Diagnostic investigations for the etiology of anemia were inadequately ordered, leading to a significant majority of anemic patients with advanced stages...
Highlights 0:08 Knowledge of metformin, its potential benefit for retinal diseases 5:02 Protective effect of metformin in geographic atrophy 8:02 What does metformin offer for GA?...
Credit: Adobe Stock/eddows Clinical, endoscopic, and laboratory assessments revealed the infliximab biosimilar CT-P13 was comparable to the reference drug in terms of safety and efficacy among...
Yanjie Hao, PhD Credit: Asia Pacific Lupus Collaboration A treat-to-target (T2T) strategy was shown to significantly improve both clinical outcomes and health-related quality of life (HRQoL)...
A matching-adjusted indirect comparison of eGFR slopes from the PROTECT trial, the NefIgArd trial, and the RaDaR registry is offering new insight into the effects of...